NCT06025331 Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?
| NCT ID | NCT06025331 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lovisenberg Diakonale Hospital |
| Condition | Arthroplasty, Replacement, Shoulder |
| Study Type | INTERVENTIONAL |
| Enrollment | 130 participants |
| Start Date | 2023-09-15 |
| Primary Completion | 2033-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 130 participants in total. It began in 2023-09-15 with a primary completion date of 2033-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare two different types of reverse shoulder replacements. Researchers will compare a conventional reverse shoulder replacement with a lateralized reverse shoulder replacement to see if there is a difference in how well the patients function after two years.
Eligibility Criteria
Inclusion Criteria: * Eligible for primary RSA due to OA, massive RC tear, failed RC repair or post-instability osteoarthritis * Able to read or write Norwegian Exclusion Criteria: * Severe osteoporosis * Osteonecrosis of the humeral head * Dementia * Poor deltoid function * Revision surgery * ASA IV * Suspected chronic infection * Acute fracture
Contact & Investigator
Sigbjørn Dimmen, PhD
PRINCIPAL INVESTIGATOR
University of Oslo
Frequently Asked Questions
Who can join the NCT06025331 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, up to 80 Years, studying Arthroplasty, Replacement, Shoulder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06025331 currently recruiting?
Yes, NCT06025331 is actively recruiting participants. Contact the research team at KjerstiKaul.Jenssen@lds.no for enrollment information.
Where is the NCT06025331 trial being conducted?
This trial is being conducted at Skien, Norway, Oslo, Norway.
Who is sponsoring the NCT06025331 clinical trial?
NCT06025331 is sponsored by Lovisenberg Diakonale Hospital. The principal investigator is Sigbjørn Dimmen, PhD at University of Oslo. The trial plans to enroll 130 participants.